TAK
Takeda Pharmaceutical Stock Analysis
AI Rating
- Quality6/10
- Growth↓ 2/10
- Value↑ 5/10
TAK Growth
- Revenue Y/Y↓ -2.50%
- EPS Y/Y↓ -45.36%
- FCF Y/Y↑ 14.58%
TAK Profitability
- Gross margin ↑ 65.30%
- EPS margin↓ 2.50%
- ROIC 5Y↓ 5.44%
TAK Dividends
- Dividend yield 3.53%
- Growth 3Y↑ 2.51%
- Payout ratio↑ 2%
TAK Risk
- Debt / Equity↓ 0.7
- Debt / FCF↓ 5.0
- Interest coverage↓ 1.6
Takeda Pharmaceutical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.